{
    "id": "35818f71-8d18-1daa-e063-6394a90aeb9f",
    "indications": "Fludrocortisone acetate tablets, 0.1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome.",
    "contraindications": "Dosage depends on the severity of the disease and the response of the patient. Patients should be continually monitored for signs that indicate dosage adjustment is necessary, such as remission or exacerbations of the disease and stress (surgery, infection, trauma) (see \n  \n                        WARNINGS\n                     \n                     and \n  \n                        PRECAUTIONS, General\n                     ).",
    "warningsAndPrecautions": "Fludrocortisone Acetate Tablets USP, \n  0.1 mg â€“ Each white to off-white, round, convex tablet debossed with a \"7033\" on one side and with a bisect on the other side.\n  \nUnit dose packages of 50 (5 x 10) NDC 68084-288-65\n  \nUnit dose packages of 100 (10 x 10) NDC 68084-288-01",
    "adverseReactions": "Corticosteroids are contraindicated in patients with systemic fungal infections and in those with a history of possible or known hypersensitivity to these agents.",
    "ingredients": [
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FLUDROCORTISONE ACETATE",
            "code": "V47IF0PVH4"
        }
    ],
    "organization": "American Health Packaging",
    "name": "Fludrocortisone Acetate",
    "effectiveTime": "20250519"
}